Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Cell fate: Transition loses its invasive edge.

Maheswaran S, Haber DA.

Nature. 2015 Nov 26;527(7579):452-3. doi: 10.1038/nature16313. Epub 2015 Nov 11. No abstract available.

PMID:
26560026
2.

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, Schwabe RF, Vahdat LT, Altorki NK, Mittal V, Gao D.

Nature. 2015 Nov 26;527(7579):472-6. doi: 10.1038/nature15748. Epub 2015 Nov 11.

3.

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R.

Nature. 2015 Nov 26;527(7579):525-530. doi: 10.1038/nature16064. Epub 2015 Nov 11.

4.

Efficacy of Cicaprost on metastasis in advanced tumor disease.

Schirner M, Lichtner RB, Graf H, Schneider MR.

Adv Exp Med Biol. 1997;400B:751-6. No abstract available.

PMID:
9547626
5.

Antimetastatic effect of amiloride in an animal tumour model.

Kellen JA, Mirakian A, Kolin A.

Anticancer Res. 1988 Nov-Dec;8(6):1373-6.

PMID:
3218971
6.

An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.

Park CY, Min KN, Son JY, Park SY, Nam JS, Kim DK, Sheen YY.

Cancer Lett. 2014 Aug 28;351(1):72-80. doi: 10.1016/j.canlet.2014.05.006. Epub 2014 Jun 2.

PMID:
24887560
7.

[Mechanism of tumor metastasis--cell-to-cell interaction].

Hamada J, Takeichi N, Kobayashi H.

Nihon Rinsho. 1987 Dec;45(12):3001-9. Review. Japanese. No abstract available.

PMID:
3328803
8.

Study of tumor metastasis in athymic nude mice.

Fujii G, Sekiguchi M, Samaru Y, Miyamoto Y, Yamamoto M, Suzuki K, Sudo K.

Jpn J Exp Med. 1979 Jun;49(3):217-8. No abstract available.

PMID:
491266
9.

E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.

Palen K, Weber J, Dwinell MB, Johnson BD, Ramchandran R, Gershan JA.

Oncotarget. 2016 Jul 12;7(28):43363-43375. doi: 10.18632/oncotarget.9715.

10.

Mouse mammary tumor metastases in lung: an electron microscopic study.

Brooks RE.

Cancer Res. 1970 Aug;30(8):2156-65. No abstract available.

11.

Loss of spontaneous metastasizing potential in mouse mammary tumors.

Vaage J.

Clin Exp Metastasis. 1989 May-Jun;7(3):373-8.

PMID:
2924453
12.

Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies.

Hanker AB, Pfefferle AD, Balko JM, Kuba MG, Young CD, Sánchez V, Sutton CR, Cheng H, Perou CM, Zhao JJ, Cook RS, Arteaga CL.

Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14372-7. doi: 10.1073/pnas.1303204110. Epub 2013 Aug 12.

13.

Experimental preoperative chemotherapy.

van Putten LM.

Recent Results Cancer Res. 1986;103:36-40. No abstract available.

PMID:
3461512
14.

Pancreatic cancer stem cells: emerging target for designing novel therapy.

Li Y, Kong D, Ahmad A, Bao B, Sarkar FH.

Cancer Lett. 2013 Sep 10;338(1):94-100. doi: 10.1016/j.canlet.2012.03.018. Epub 2012 Mar 20. Review.

15.

[Therapy experiments on autochthonic mammary carcinoma in rats].

Fretz J, Rohde W, Schmähl D, Thomas C.

Arzneimittelforschung. 1969 Aug;19(8):1291-5. German. No abstract available.

PMID:
5820295
16.

Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.

Yoneura N, Takano S, Yoshitomi H, Nakata Y, Shimazaki R, Kagawa S, Furukawa K, Takayashiki T, Kuboki S, Miyazaki M, Ohtsuka M.

Int J Mol Med. 2018 Aug;42(2):821-830. doi: 10.3892/ijmm.2018.3652. Epub 2018 May 2.

17.
18.

Effects of x-irradiation on parameters of tumor growth, histology, and ultrastructure.

Fisher ER, Fisher B.

Cancer. 1969 Jul;24(1):39-55. No abstract available.

PMID:
5790289
19.

Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs.

Chung JH, Rho JK, Xu X, Lee JS, Yoon HI, Lee CT, Choi YJ, Kim HR, Kim CH, Lee JC.

Lung Cancer. 2011 Aug;73(2):176-82. doi: 10.1016/j.lungcan.2010.11.011. Epub 2010 Dec 17.

PMID:
21168239

Supplemental Content

Support Center